PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50121F33010Procure a influenza a(h2nx) VIRUS vaccine — Seqirus Inc

Seqirus Inc holds $419.6M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Recompete timing centers on the Jan 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Seqirus Inc
Recipient
Jan 31, 2027
PoP end
$21.4M
Obligated
541714
NAICS
AN14
PSC
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75A50121F33010
Also listed as75A50118D00004-75A50121F33010
AgencyBarda - Aspr / Daappo / Barda Dcma
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentSeqirus Inc
UEIZ6N1LJ2RD6E3
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14
Parent IDIQ / IDV75A50118D00004
Place of performanceHOLLY SPRINGS, NC
PoP end (current)Jan 31, 2027
Obligated$21.4M

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Seqirus Inc. Estimated value $35M ($21.4M obligated). Current period of performance ends Jan 31, 2027. Last award drew 2 bidders. Place of performance: HOLLY SPRINGS, NC.

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL

Recompete timing

Public
● Expiring in 123 days

Current PoP ends Jan 31, 2027 (123 days remaining). Agencies typically plan 12–18 months ahead — at 4.0 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75A50121F33010? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Seqirus Inc — $419.6M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$419.6M · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50121F33010?

75A50121F33010 (Procure a influenza a(h2nx) VIRUS vaccine) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $35M, currently held by Seqirus Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50121F33010?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50121F33010 to Seqirus Inc.

Who is the incumbent on 75A50121F33010?

Seqirus Inc is the incumbent with $419.6M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2027.

When does Seqirus Inc’s 75A50121F33010 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50121F33010? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50121F33010